
HORIZON (OP-106) Study of Melflufen in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Refractory to Daratumumab and/or Pomalidomide: Updated Efficacy and Safety
Richardson, Paul G., Oriol, Albert, Larocca, Alessandra, Otero, Paula Rodriguez, Norkin, Maxim, Bladé, Joan, Cavo, Michele, Hassoun, Hani, Leleu, Xavier, Alegre, Adrián, Maisel, Christopher, Paner, AgVolume:
19
Langue:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2019.07.318
Date:
September, 2019
Fichier:
PDF, 97 KB
english, 2019